Replies to post #196709 on Biotech Values

[DewDiligence]

SHPG-DYAX CC slides:

https://t.co/TAMbdCpBNa

[DewDiligence]

DYAX deal does not lessen SHPG's (hostile) pursuit of BXLT, according to SHPG's comments today.

[DewDiligence]

Former DYAX shareholders get $4/sh CVR milestone payment from FDA approval of SHPG’s Takhzyro (f/k/a DX-2930) for HAE preventive use:

https://finance.yahoo.com/news/shire-announces-fda-approval-takhzyro-060000988.html